Pharmacological treatment effects on eye movement control

[1]  J. Kanto,et al.  Saccadic eye movements in determination of the residual effects of flunitrazepam. , 2009, Acta pharmacologica et toxicologica.

[2]  K. Johnston,et al.  Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates , 2008, Brain and Cognition.

[3]  N. Smyrnis.  Metric issues in the study of eye movements in psychiatry , 2008, Brain and Cognition.

[4]  R. Lencer,et al.  Neurophysiology and neuroanatomy of smooth pursuit in humans , 2008, Brain and Cognition.

[5]  B. Clementz,et al.  Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans , 2008, Brain and Cognition.

[6]  S. Hutton.  Cognitive control of saccadic eye movements , 2008, Brain and Cognition.

[7]  P. Thier,et al.  The neural basis of smooth pursuit eye movements in the rhesus monkey brain , 2008, Brain and Cognition.

[8]  Edward D Levin,et al.  Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. , 2007, Biochemical pharmacology.

[9]  J. Sweeney,et al.  Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia. , 2007, Schizophrenia bulletin.

[10]  J. Sweeney,et al.  Antipsychotic Drugs Exacerbate Impairment on a Working Memory Task in First-Episode Schizophrenia , 2007, Biological Psychiatry.

[11]  J. Rusted,et al.  Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison , 2007, Psychopharmacology.

[12]  Wouter Hulstijn,et al.  Psychomotor and Memory Effects of Haloperidol, Olanzapine, and Paroxetine in Healthy Subjects After Short-Term Administration , 2007, Journal of clinical psychopharmacology.

[13]  W. Iacono,et al.  The association between lithium carbonate and smooth pursuit eye tracking among first-episode patients with psychotic affective disorders. , 2007, Psychophysiology.

[14]  A. Sereno,et al.  Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  J. Sweeney,et al.  Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. , 2006, Archives of general psychiatry.

[16]  J. Rusted,et al.  The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine , 2006, Psychopharmacology.

[17]  J. Tanabe,et al.  Effects of Nicotine on Hippocampal and Cingulate Activity During Smooth Pursuit Eye Movement in Schizophrenia , 2006, Biological Psychiatry.

[18]  G. Thaker,et al.  Effects of repeated amphetamine administration on antisaccades in schizophrenia spectrum personality , 2006, Psychiatry Research.

[19]  R. Carpenter,et al.  Saccadic latency distributions in Parkinson’s disease and the effects of l-dopa , 2006, Experimental Brain Research.

[20]  Matcheri S Keshavan,et al.  Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia , 2006, Psychological Medicine.

[21]  G. O'driscoll,et al.  Executive Functions and Methylphenidate Response in Subtypes of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[22]  B. Gaymard,et al.  Ketamine-induced distractibility: An oculomotor study in monkeys , 2005, Biological Psychiatry.

[23]  J. Tanabe,et al.  FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia. , 2005, The American journal of psychiatry.

[24]  J. Sweeney,et al.  Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia , 2005, Biological Psychiatry.

[25]  A. Sereno,et al.  Nicotine improves antisaccade task performance without affecting prosaccades , 2004, Human psychopharmacology.

[26]  D. Gooding,et al.  Temporal stability of saccadic task performance in schizophrenia and bipolar patients , 2004, Psychological Medicine.

[27]  R J Leigh,et al.  Using saccades as a research tool in the clinical neurosciences. , 2004, Brain : a journal of neurology.

[28]  R Bell,et al.  Effects of Amisulpride, Risperidone and Chlorpromazine on Auditory and Visual Latent Inhibition, Prepulse Inhibition, Executive Function and Eye Movements in Healthy Volunteers , 2004, Journal of psychopharmacology.

[29]  A. Sereno,et al.  Nicotine reduces antisaccade errors in task impaired schizophrenic subjects , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  C. Kennard,et al.  Using saccades as a research tool in the clinical neurosciences , 2004 .

[31]  G. Thaker,et al.  Effects of Nicotine on Leading Saccades during Smooth Pursuit Eye Movements in Smokers and Nonsmokers with Schizophrenia , 2003, Neuropsychopharmacology.

[32]  Ulrich Ettinger,et al.  Effects of Procyclidine on Eye Movements in Schizophrenia , 2003, Neuropsychopharmacology.

[33]  Ulrich Ettinger and Veena Kumari,et al.  Pharmacological Studies of Smooth Pursuit and Antisaccade Eye Movements in Schizophrenia: Current Status and Directions for Future Research , 2003 .

[34]  M. Danhof,et al.  A study of the effects of long-term use on individual sensitivity to temazepam and lorazepam in a clinical population. , 2003, British journal of clinical pharmacology.

[35]  M. Pieters,et al.  The Psychomotor Effects of Carbamazepine in Epileptic Patients and Healthy Volunteers , 2003, Journal of psychopharmacology.

[36]  J. Hauser,et al.  The Study of Cytosolic Phospholipase A2 Gene Polymorphism in Schizophrenia Using Eye Movement Disturbances as an Endophenotypic Marker , 2003, Neuropsychobiology.

[37]  A. Olincy,et al.  Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia , 2003, Psychiatry Research.

[38]  J. Hauser,et al.  Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene , 2002, Psychiatry Research.

[39]  S. Lal,et al.  Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study , 2002, Neuropsychopharmacology.

[40]  A F Cohen,et al.  Biomarkers for the effects of benzodiazepines in healthy volunteers. , 2002, British journal of clinical pharmacology.

[41]  T. Crawford,et al.  Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[42]  Teresa A Blaxton,et al.  The effects of nicotine on specific eye tracking measures in schizophrenia , 2002, Biological Psychiatry.

[43]  C. Tamminga,et al.  Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. , 2002, The American journal of psychiatry.

[44]  D. Nutt,et al.  Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood , 2002, Journal of psychopharmacology.

[45]  Yasushi Kobayashi,et al.  Sensory-motor gating and cognitive control by the brainstem cholinergic system , 2002, Neural Networks.

[46]  C. Klein,et al.  Effects of methylphenidate on saccadic responses in patients with ADHD , 2002, Experimental Brain Research.

[47]  M. Reveley,et al.  Improved antisaccade performance with risperidone in schizophrenia , 2002, Journal of neurology, neurosurgery, and psychiatry.

[48]  B. Steinacher,et al.  Smooth pursuit eye movements of patients with schizophrenia and affective disorder during clinical treatment , 2002, European Archives of Psychiatry and Clinical Neuroscience.

[49]  Robbert Jan Verkes,et al.  Saccadic peak velocity and EEG as end‐points for a serotonergic challenge test , 2002, Human psychopharmacology.

[50]  G. Tribl,et al.  High-dose olanzapine in Huntington's disease. , 2002, International clinical psychopharmacology.

[51]  W. Eddy,et al.  Pursuit and saccadic eye movement subregions in human frontal eye field: a high-resolution fMRI investigation. , 2002, Cerebral cortex.

[52]  J. Powell,et al.  Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model , 2002, Biological Psychiatry.

[53]  J. Deakin,et al.  Effects of the 5HT antagonist cyproheptadine on neuropsychological function in chronic schizophrenia , 2002, Schizophrenia Research.

[54]  J. Hauser,et al.  Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects , 2001, Molecular Psychiatry.

[55]  S. H. Mostofsky,et al.  Oculomotor abnormalities in attention deficit hyperactivity disorder , 2001, Neurology.

[56]  J. V. van Gerven,et al.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers. , 2001, British journal of clinical pharmacology.

[57]  C. Tamminga,et al.  Ketamine Effects on Eye Movements , 2000, Neuropsychopharmacology.

[58]  L. Crevits,et al.  Antisaccadic Effects of a Dopamine Agonist as Add-On Therapy in Advanced Parkinson’s Patients , 2000, Neuropsychobiology.

[59]  S. Dursun,et al.  The effects of antipsychotic medication on saccadic eye movement abnormalities in Huntington's disease , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[60]  T. Ketter,et al.  Psychiatric phenomenology of child and adolescent bipolar offspring. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[61]  P. Goldman-Rakic,et al.  Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.

[62]  O. Rascol,et al.  Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors , 2000, Behavioural Brain Research.

[63]  J F Green,et al.  Antisaccade and smooth pursuit eye movements in healthy subjects receiving sertraline and lorazepam , 2000, Journal of psychopharmacology.

[64]  Robert W. Buchanan,et al.  Smooth pursuit eye movements to extra-retinal motion signals: deficits in patients with schizophrenia , 1999, Psychiatry Research.

[65]  M. Thase,et al.  Pursuit tracking impairments in schizophrenia and mood disorders: step-ramp studies with unmedicated patients , 1999, Biological Psychiatry.

[66]  T. Isa,et al.  Injection of nicotine into the superior colliculus facilitates occurrence of express saccades in monkeys. , 1999, Journal of neurophysiology.

[67]  David Goldman,et al.  Relationship Between a GABAAα6 Pro385Ser Substitution and Benzodiazepine Sensitivity , 1999, American Journal of Psychiatry.

[68]  M. Segraves,et al.  Muscimol-induced inactivation of monkey frontal eye field: effects on visually and memory-guided saccades. , 1999, Journal of neurophysiology.

[69]  R. S. Payne,et al.  An Increase in Lactate Output by Brain Tissue Serves to Meet the Energy Needs of Glutamate-Activated Neurons , 1999, The Journal of Neuroscience.

[70]  A. Radant,et al.  Does Ketamine-Mediated N-methyl-D-aspartate Receptor Antagonism Cause Schizophrenia-like Oculomotor Abnormalities? , 1998, Neuropsychopharmacology.

[71]  J. Sweeney,et al.  Eye tracking abnormalities in schizophrenia: evidence for dysfunction in the frontal eye fields , 1998, Biological Psychiatry.

[72]  D. King,et al.  The effects of chlorpromazine and lorazepam on abnormal antisaccade and no-saccade distractibility , 1998, Biological Psychiatry.

[73]  B. Pennington,et al.  A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right parietal lobe theories. , 1998, Developmental psychology.

[74]  M. Ferrari,et al.  Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers. , 1998, Journal of clinical psychopharmacology.

[75]  C. Bruce,et al.  Deficits in smooth-pursuit eye movements after muscimol inactivation within the primate's frontal eye field. , 1998, Journal of neurophysiology.

[76]  S. Noachtar,et al.  Gabapentin and carbamazepine affect eye movements and posture control differently: A placebo-controlled investigation of acute CNS side effects in healthy volunteers , 1998, Epilepsy Research.

[77]  C Kennard,et al.  Smooth pursuit and saccadic abnormalities in first-episode schizophrenia , 1998, Psychological Medicine.

[78]  J. Sweeney,et al.  Do Alprazolam‐Induced Changes in Saccadic Eye Movement and Psychomotor Function Follow the Same Time Course? , 1998, Journal of clinical pharmacology.

[79]  P. Goldman-Rakic,et al.  Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. , 1998, Archives of general psychiatry.

[80]  R. Freedman,et al.  Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients , 1998, Neuropsychopharmacology.

[81]  D. Zee,et al.  Ocular motor abnormalities in Huntington's disease , 1997, Vision Research.

[82]  T. Duka,et al.  The effects of incentive on antisaccades: is a dopaminergic mechanism involved? , 1997, Behavioural pharmacology.

[83]  K. Stevens,et al.  Normalizing Effects of Nicotine and a Novel Nicotinic Agonist on Hippocampal Auditory Gating in Two Animal Models , 1997, Pharmacology Biochemistry and Behavior.

[84]  N L Foster,et al.  Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease , 1997, Neurology.

[85]  L. Ni,et al.  Effects of tobacco smoking on human ocular smooth pursuit , 1997, Clinical pharmacology and therapeutics.

[86]  J. Sweeney,et al.  Adverse Effects of Risperidone on Eye Movement Activity: A Comparison of Risperidone and Haloperidol in Antipsychotic-Naive Schizophrenic Patients , 1997, Neuropsychopharmacology.

[87]  D. King,et al.  A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam , 1996, Psychopharmacology.

[88]  M. Grealy,et al.  Abnormalities of smooth eye and head movement control in parhson's disease , 1996, Annals of neurology.

[89]  B. J. McCurtain,et al.  Functional MRI studies of reflexive and voluntary saccadic eye movements , 1996, NeuroImage.

[90]  M. Segraves,et al.  Acute activation and inactivation of macaque frontal eye field with GABA-related drugs. , 1995, Journal of neurophysiology.

[91]  R. Freedman,et al.  Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia , 1995, Biological Psychiatry.

[92]  L. Henderson,et al.  Saccadic abnormalities in psychotic patients. II. The role of neuroleptic treatment , 1995, Psychological Medicine.

[93]  M. Trivedi,et al.  Fluoxetine and Oculomotor Activity during Sleep in Depressed Patients , 1995, Neuropsychopharmacology.

[94]  B. Tiplady,et al.  The effects of remoxipride and chlorpromazine on eye movements and psychomotor performance in healthy volunteers , 1995, Journal of psychopharmacology.

[95]  D. Levy,et al.  Functional neuroanatomy of antisaccade eye movements investigated with positron emission tomography. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J. Fukushima,et al.  Relationship between antisaccades and the clinical symptoms in Parkinson's disease , 1994, Neurology.

[97]  P. Weiden,et al.  Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia , 1994, Psychiatry Research.

[98]  H. Sackeim,et al.  Effects of pharmacologic catecholamine manipulation on smooth pursuit eye movements in normals , 1994, Schizophrenia Research.

[99]  J. Jesberger,et al.  The Effect of Apomorphine, MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine) and Placebo on Smooth Pursuit Gain and Corrective Saccades in Normal Subjects , 1994, Neuropsychopharmacology.

[100]  D. Hommer,et al.  Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia , 1994, Schizophrenia Research.

[101]  D. King.  Psychomotor impairment and cognitive disturbances induced by neuroleptics , 1994, Acta psychiatrica Scandinavica. Supplementum.

[102]  D. Hommer,et al.  Eye movement effects of diazepam in sons of alcoholic fathers and male control subjects. , 1994, Alcoholism, clinical and experimental research.

[103]  Y. Agid,et al.  Sequences of memory‐guided saccades in Parkinson's disease , 1994, Annals of neurology.

[104]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[105]  P. Goldman-Rakic,et al.  The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. , 1994, Journal of neurophysiology.

[106]  D. J. King,et al.  The effects of haloperidol on visual search, eye movements and psychomotor performance , 1993, European Neuropsychopharmacology.

[107]  R. Wurtz,et al.  Fixation cells in monkey superior colliculus. I. Characteristics of cell discharge. , 1993, Journal of neurophysiology.

[108]  D. Hommer,et al.  Personality and benzodiazepine sensitivity in anxious patients and control subjects , 1993, Psychiatry Research.

[109]  R Both,et al.  Adaptive mechanisms of saccadic system in diagnostic use. , 1993, Electromyography and clinical neurophysiology.

[110]  W. King,et al.  Quantitative longitudinal assessment of saccades in Huntington's disease. , 1993, Journal of clinical neuro-ophthalmology.

[111]  R Fioravanti,et al.  Impairment of Saccadic Eye Movements by Scopolamine Treatment , 1993, Perceptual and motor skills.

[112]  B. Weatherley,et al.  Carbamazepine and Lamotrigine in Healthy Volunteers: Relevance to Early Tolerance and Clinical Trial Dosage , 1993, Epilepsia.

[113]  D. Campion,et al.  SPEM impairment in drug-naive schizophrenic patients: Evidence for a trait marker , 1992, Biological Psychiatry.

[114]  K. Frick,et al.  Lithium effect on smooth pursuit eye movements of healthy volunteers , 1992, Biological Psychiatry.

[115]  H. Schoemaker,et al.  Effects of temazepam on saccadic eye movements: Concentration‐effect relationships in individual volunteers , 1992, Clinical pharmacology and therapeutics.

[116]  I. Marshall,et al.  Eye-tracking dysfunction in the affective psychoses and schizophrenia , 1992, Psychological Medicine.

[117]  G. Zaccara,et al.  Effects of oxcarbazepine and carbamazepine on the central nervous system: computerised analysis of saccadic and smooth‐pursuit eye movements , 1992, Acta neurologica Scandinavica.

[118]  Meindert Danhof,et al.  Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers , 1992, Clinical pharmacology and therapeutics.

[119]  M. Mahowald,et al.  Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. , 1992, Sleep.

[120]  J. Jesberger,et al.  Effect of typical antipsychotic medications and clozapine on smooth pursuit performance in patients with schizophrenia , 1992, Psychiatry Research.

[121]  G. Tedeschi,et al.  A pharmacodynamic study of quazepam and triazolam , 1991 .

[122]  D. Nutt,et al.  Pharmacology of saccadic eye movements in man , 1991, Psychopharmacology.

[123]  P. Glue.  Merck, Sharp & Dohme Prize for Young Psychopharmacologists , 1991, Journal of psychopharmacology.

[124]  A. W. Peck.  Clinical Pharmacology of Lamotrigine , 1991, Epilepsia.

[125]  P. Holzman,et al.  Effects of lithium treatment on eye movements , 1991, Biological Psychiatry.

[126]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[127]  M. Blom,et al.  The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG , 1990, Fundamental & clinical pharmacology.

[128]  P. Mettens,et al.  Ketamine induces failure of the oculomotor neural integrator in the cat , 1990, Neuroscience Letters.

[129]  D. Hommer,et al.  Reduced benzodiazepine sensitivity in panic disorder. , 1990, Archives of general psychiatry.

[130]  J. Vercher,et al.  Pyridostigmine-induced inhibition of blood acetylcholinesterase (AChE) and resulting effects on manual ocular tracking performance in the trained baboon. , 1990, Behavioral and neural biology.

[131]  R. Leigh,et al.  The characteristics and mechanisms of visual disturbance associated with anticonvulsant therapy , 1990, Neurology.

[132]  W. Schultz,et al.  Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP- treated monkeys , 1989, Experimental Brain Research.

[133]  M. Simonetta,et al.  Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems. , 1989, Brain : a journal of neurology.

[134]  R. Wurtz,et al.  The Neurobiology of Saccadic Eye Movements , 1989 .

[135]  J. Sweeney,et al.  Changes in eye tracking during clinical stabilization in Schizophrenia , 1989, Psychiatry Research.

[136]  R. T. Pivik,et al.  The effects of background illumination and stimulant medication on smooth pursuit eye movements of hyperactive children , 1989, Journal of abnormal child psychology.

[137]  K. Schaffler,et al.  Placebo-Controlled Study on Acute and Subchronic Effects of Buspirone vs Bromazepam Utilizing Psychomotor and Cognitive Assessments in Healthy Volunteers , 1989, Pharmacopsychiatry.

[138]  D. Penetar,et al.  Combined atropine and 2-PAM Cl effects on tracking performance and visual, physiological, and psychological functions. , 1988, Aviation, space, and environmental medicine.

[139]  J. Spray,et al.  The effect of neuroleptics and tardive dyskinesia on smooth-pursuit eye movement in chronic schizophrenics. , 1988, Archives of general psychiatry.

[140]  K. Manning,et al.  The effects of tobacco smoking on smooth pursuit eye movements , 1988, Annals of neurology.

[141]  J. Sharpe,et al.  Smooth pursuit during dose‐related on‐off fluctuations in Parkinson's disease , 1987, Neurology.

[142]  C Kennard,et al.  Ocular motor and manual tracking in Parkinson's disease and the effect of treatment. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[143]  C. Marsden,et al.  Simple and complex movements off and on treatment in patients with Parkinson's disease. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[144]  G. Chrousos,et al.  Two cases of downbeat nystagmus and oscillopsia associated with carbamazepine. , 1987, American journal of ophthalmology.

[145]  G. Tedeschi,et al.  The effects of repeated doses of temazepam and nitrazepam on several measures of human performance , 1986, Acta psychiatrica Scandinavica. Supplementum.

[146]  P. Anderer,et al.  Quantitative EEG, SPEM, and Psychometric Studies in Schizophrenics before and during Differential Neuroleptic Therapy , 1986, Pharmacopsychiatry.

[147]  B. A. Brooks,et al.  Saccadic eye movement deficits in the MPTP monkey model of Parkinson's disease , 1986, Brain Research.

[148]  E. Gershon,et al.  Clinical methods in psychiatric genetics: II. The high risk approach , 1986, Acta psychiatrica Scandinavica.

[149]  D. Hommer,et al.  Benzodiazepine sensitivity in normal human subjects. , 1986, Archives of general psychiatry.

[150]  C. Schuster,et al.  Effects of dopaminergic agents on eye tracking before and after repeated methamphetamine , 1986, Pharmacology Biochemistry and Behavior.

[151]  R. Wolf,et al.  Visually stimulated saccadic eye movements in patients treated with lithium , 1986, Acta psychiatrica Scandinavica.

[152]  A. Cohen,et al.  Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. , 1985, British journal of clinical pharmacology.

[153]  A. T. Smith,et al.  The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. , 1985, British journal of clinical pharmacology.

[154]  L. Coyne,et al.  Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. , 1985, Archives of general psychiatry.

[155]  P. Clarke,et al.  Electrophysiological actions of nicotine on substantia nigra single units , 1985, British journal of pharmacology.

[156]  B. Berggren,et al.  Smooth pursuit eye tracking, neuropsychological test performance, and computed tomography in schizophrenia , 1985, Psychiatry Research.

[157]  D. Levy,et al.  Pharmacologic evidence for specificity of pursuit dysfunction to schizophrenia. Lithium carbonate associated with abnormal pursuit. , 1985, Archives of general psychiatry.

[158]  C. Bruce,et al.  Primate frontal eye fields. I. Single neurons discharging before saccades. , 1985, Journal of neurophysiology.

[159]  A. Bartfai,et al.  Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients. , 1983, Biological psychiatry.

[160]  Okihide Hikosaka,et al.  Effects on eye movements of a GABA agonist and antagonist injected into monkey superior colliculus , 1983, Brain Research.

[161]  D. Levy,et al.  Eye tracking dysfunction unrelated to clinical state and treatment with haloperidol. , 1983, Biological psychiatry.

[162]  A. T. Smith,et al.  Benzodiazepines impair smooth pursuit eye movements. , 1983, British journal of clinical pharmacology.

[163]  A. T. Smith,et al.  The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. , 1981, British journal of clinical pharmacology.

[164]  D. Selkoe,et al.  Specific oculomotor deficit after diazepam , 1981, Psychopharmacology.

[165]  M. Gresty,et al.  Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[166]  Karson Cn.  Oculomotor signs in a psychiatric population: a preliminary report. , 1979 .

[167]  L. Coyne,et al.  Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. , 1977, Archives of general psychiatry.

[168]  D. Levy,et al.  Smooth-pursuit eye movements, and diazepam, CPZ, and secobarbital , 1975, Psychopharmacologia.

[169]  R. Cohen,et al.  Smooth-pursuit eye-movement dysfunction and motor control in schizophrenia: A follow-up study , 2005, European Archives of Psychiatry and Clinical Neuroscience.

[170]  D. Hommer,et al.  Benzodiazepine pharmacodynamics: utility of eye movement measures , 2005, Psychopharmacology.

[171]  G. Tedeschi,et al.  Computer analysis of saccadic eye movements: assessment of two different carbamazepine formulations , 2004, European Journal of Clinical Pharmacology.

[172]  J. Tecce,et al.  Psychophysiologic responses of schizophrenics to drugs , 2004, Psychopharmacologia.

[173]  A. T. Smith,et al.  Effect of amphetamine on saccadic and smooth pursuit eye movements , 2004, Psychopharmacology.

[174]  C. E. Johanson,et al.  Effects of phencyclidine, secobarbital and diazepam on eye tracking in rhesus monkeys , 2004, Psychopharmacology.

[175]  R. Kemm,et al.  The Basal Ganglia , 2004 .

[176]  P. Jurák,et al.  The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. , 2003, Parkinsonism & related disorders.

[177]  D. Levy,et al.  Commentary: eye movement research with clinical populations. , 2002, Progress in brain research.

[178]  Michael Riedel,et al.  Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part II. Saccadic latency, gain, and fixation suppression errors , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[179]  D. Munoz,et al.  Control of Purposive Saccadic Eye Movements and Visual Fixation in Children with Attention-Deficit Hyperactivity Disorder , 1999 .

[180]  T. Eggert,et al.  Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part I. Saccadic velocity , 1999, European Archives of Psychiatry and Clinical Neuroscience.

[181]  D. Goldman,et al.  Relationship between a GABAA alpha 6 Pro385Ser substitution and benzodiazepine sensitivity. , 1999, The American journal of psychiatry.

[182]  W. Iacono,et al.  Antisaccade performance in patients with schizophrenia and affective disorder. , 1997, Journal of abnormal psychology.

[183]  T Marek,et al.  Effects of diazepam and buspirone on reaction time of saccadic eye movements. , 1995, Neuropsychobiology.

[184]  W. Iacono,et al.  Temporal stability of smooth-pursuit eye tracking in first-episode psychosis. , 1994, Psychophysiology.

[185]  R. Baker,et al.  The pathways and functions of GABA in the oculomotor system. , 1992, Progress in brain research.

[186]  K. Korttila,et al.  Effect of intravenous diazepam and thiopental on voluntary saccades and pursuit eye movements. , 1992, Acta oto-laryngologica.

[187]  M. Ohki,et al.  Quantitative analysis of ocular movements in Parkinson's disease. , 1991, Acta oto-laryngologica. Supplementum.

[188]  H. Ashikawa,et al.  Effects of serotonin, GABA and glycine on the activity of pause neurons during vestibular nystagmus in the cat. , 1991, Acta oto-laryngologica.

[189]  A. Fuchs,et al.  Saccadic eye movement deficits following ibotenic acid lesions of the nuclei raphe interpositus and prepositus hypoglossi in monkey. , 1991, Acta oto-laryngologica. Supplementum.

[190]  D. Nutt,et al.  Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. , 1991, Psychopharmacology.

[191]  P. Anderer,et al.  Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity. , 1990, Psychopathology.

[192]  M. Verbaten,et al.  Acute effects of bromazepam on signal detection performance, digit symbol substitution test and smooth pursuit eye movements. , 1988, Neuropsychobiology.

[193]  L. Siever,et al.  Eye-tracking, attention and amphetamine challenge. , 1987, Journal of psychiatric research.

[194]  R. Wurtz,et al.  Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus. , 1985, Journal of neurophysiology.

[195]  C. Karson.  Oculomotor signs in a psychiatric population: a preliminary report. , 1979, The American journal of psychiatry.